ICU Medical, Inc.
ICUI Healthcare Medical Instruments & Supplies
ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024.
- Revenue
- +4.37%
- EPS
- +864.3%
- Free cash flow
- +292.2%
- Total debt
- −12.3%
Quarter to September 2026, against a year earlier
Follow ICUI
Alert me
ICU Medical, Inc. (ICUI) Revenue
ICU Medical, Inc.'s revenue for fiscal 2025 was $2.2B, down 6.33% from $2.4B in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.2B. Over the past ten years it has ranged from $341.7M (fiscal 2015) to $2.4B (fiscal 2024); the current reading is higher than 73% of that period. ICU Medical, Inc. ranks 18th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $2.2B | (6.33%) |
| FY2024 | $2.4B | 5.44% |
| FY2023 | $2.3B | (0.92%) |
| FY2022 | $2.3B | 73.21% |
| FY2021 | $1.3B | 3.56% |
| FY2020 | $1.3B | 0.38% |
| FY2019 | $1.3B | (9.56%) |
| FY2018 | $1.4B | 8.31% |
| FY2017 | $1.3B | 240.72% |
| FY2016 | $379.4M | 11.04% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $560.4M | 1.59% |
| Jun 2026 | $551.7M | 4.05% |
| Mar 2026 | $530.2M | (1.94%) |
| Dec 2025 | $540.7M | 0.69% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| MMED MiniMed Group, Inc. compare | $3.0B |
| NVST Envista Holdings Corporation compare | $2.9B |
| TFX Teleflex Incorporated compare | $2.3B |
| ICUI ICU Medical, Inc. | $2.2B |
| MMSI Merit Medical Systems, Inc. compare | $1.6B |
| STVN Stevanato Group S.p.A. compare | $1.4B |
| WRBY Warby Parker Inc. compare | $934.7M |
| ATRC AtriCure, Inc. compare | $589.8M |
| PLSE Pulse Biosciences, Inc compare | $1.5M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ICUI
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement